Moderna (MRNA) sees strong intraday gains Jun 3, 2026 02:14PM
Moderna to Present at Upcoming Conference in June 2026 Jun 2, 2026 07:00AM
Moderna and Merck report sustained melanoma treatment benefits at 5 years Jun 1, 2026 08:01AM
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASC Jun 1, 2026 08:00AM
Moderna receives $50 million from CEPI for Bundibugyo Ebola vaccine Jun 1, 2026 05:49AM
View Older Stories

Jun 1, 2026 05:00AM Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
May 26, 2026 09:15AM UBS Reiterates Neutral Rating on Moderna (MRNA)
May 21, 2026 02:06PM Moderna (MRNA) call put ratio 14 calls to 1 put with a focus on May 22 weekly 52, 55 and 57 calls
May 18, 2026 11:32AM Colorado public health officials investigating hantavirus death not linked to cruise ship cluster - ABC
May 15, 2026 12:55PM High School student in New York linked to suspected hantavirus case - Local report
May 14, 2026 02:12PM No Cases Of Hantavirus Infection In The US - CDC
May 12, 2026 05:00PM Moderna Recognized by TIME as One of the World's Most Impactful Companies
May 12, 2026 12:53PM FDA Commissioner Marty Makary to step down - Politico
May 12, 2026 12:06PM WHO expects additional cases of hantavirus, but no wider outbreak seen
May 12, 2026 08:42AM Bernstein: 'Hantavirus boosting interest in Moderna (MRNA)'
May 11, 2026 11:25AM 1 Hantavirus Suspected Case In Nebraska Is Dual US-UK Citizen - Bloomberg
May 11, 2026 10:23AM HHS downplays Hantavirus risk amid repatriation efforts
May 11, 2026 06:53AM Moderna shares jump 8% after U.S. national tests positive for hantavirus
May 11, 2026 06:25AM Moderna (MRNA) call put ratio 7.4 calls to 1 put amid wide price movement
May 11, 2026 06:09AM Stocks expected to have increasing option volume: CRCL PBR B CEG SPG HIMS MOS PLUG MNDY ASTS FOXA DELL MRNA
May 8, 2026 12:29PM Moderna Is Working On Early-stage Hantavirus Vaccines - Bloomberg
May 6, 2026 05:16PM Moderna flu vaccine shows superior efficacy in phase 3 study
May 6, 2026 05:16PM Moderna flu vaccine data published in medical journal
May 6, 2026 05:15PM Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
May 1, 2026 12:25PM Moderna (MRNA) PT Raised to $38 at RBC Capital
May 1, 2026 10:25AM Moderna (MRNA) PT Raised to $32 at BofA Securities
May 1, 2026 06:37AM Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue
May 1, 2026 06:30AM Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
Apr 30, 2026 11:14AM Moderna (MRNA) call put ratio 2 calls to 1 put with a focus on May 1 weekly 55 calls into quarter results
Apr 30, 2026 03:35AM Moderna (MRNA) call put ratio 1 calls to 1 put with a focus on June options into quarter results
Apr 21, 2026 07:01PM Moderna begins phase 3 trial of mRNA bird flu vaccine
Apr 21, 2026 07:01PM Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
Apr 21, 2026 10:00AM Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
Apr 21, 2026 09:41AM Moderna receives EU approval for first flu-COVID combination vaccine
Apr 21, 2026 09:40AM Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19
Apr 21, 2026 07:00AM Moderna to Present at Upcoming Conferences in May 2026
Apr 17, 2026 03:00PM Moderna presents melanoma therapy data showing 83% response rate
Apr 17, 2026 03:00PM Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026
Apr 15, 2026 07:00AM Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
Apr 6, 2026 06:01PM Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
Mar 16, 2026 03:46PM US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
Mar 4, 2026 08:36AM Moderna shares jump as settlement removes major legal overhang
Mar 4, 2026 05:27AM Moderna (MRNA) call put ratio 2.4 calls to 1 put into resolves litigation
Mar 3, 2026 05:15PM Jefferies Reiterates Hold Rating on Moderna (MRNA): "cash breakeven guidance is clearer"
Mar 3, 2026 04:33PM After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
Mar 3, 2026 04:15PM Moderna settles patent dispute with Arbutus for $950 million
Mar 3, 2026 04:15PM Moderna Resolves Global Patent Litigation with Arbutus/Genevant
Feb 27, 2026 07:03AM EMA committee recommends approval for Moderna's flu-COVID combo vaccine
Feb 27, 2026 07:00AM European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influen
Feb 26, 2026 11:53AM Stifel: 'We can see why QURE shares are lower on CNBC comments from FDA'
Feb 23, 2026 08:41AM Moderna (MRNA) PT Raised to $69 at Piper Sandler
Feb 19, 2026 01:15PM BioNTech sues Moderna for U.S. patent infringement over covid vaccine MNEXspike - Court filing
Feb 19, 2026 07:00AM Moderna to Present at Upcoming Conferences in March 2026
Feb 18, 2026 07:01AM FDA accepts Moderna flu vaccine application for review
Feb 18, 2026 07:00AM Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
View Older Stories